Treating Cancer-Related Anxiety with Psychedelic Mushrooms
the MPR take:
Psilocybin, a Schedule I controlled substance, is being studied as a potential treatment for cancer-related anxiety. At NYU, Dr. Stephen Ross has been experimenting with this hallucinogenic, administering the drug to cancer patients and analyzing its effects. Data from the study show a reduction in anxiety that is immediate and sustained with 3/4 of patients rating the experience as being one of the most significant events in their lives. Unlike benzodiazepines, which only offer temporary anxiety relief, patients report enduring effects with psilocybin, even with just one dose. Further analysis still needs to be done to see if psilocybin will be accepted as an approved therapy. At this time, given its status with the DEA, the drug is still considered to have no accepted medical use and carries high abuse potential.
READ FULL ARTICLE From The Atlantic